key: cord-0884820-v8oxuz4a authors: Njoku, Ihuoma O.; Aggarwal, Ayushi; Bamgartner, Michele; Lever, Jacelyn E. P.; Fleming, Talya K. title: Letter regarding “Outcomes of a COVID‐19 recovery program for patients hospitalized with SARS‐CoV‐2 infection in New York City: A prospective cohort study” date: 2021-07-20 journal: PM R DOI: 10.1002/pmrj.12653 sha: 1e6408833153cd957a1b9a803275e9f2dfde2712 doc_id: 884820 cord_uid: v8oxuz4a nan Editor, We were very interested to read the study conducted by Hameed et al in the article "Outcomes of a COVID-19 recovery program for patients hospitalized with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection in New York City: A prospective cohort study." 1 The contrast between a virtual outpatient rehabilitation program and a home physical therapy program for patients recovering from coronavirus disease 2019 (COVID-19) demonstrated the need for close post-discharge follow-up in improving health outcomes of patients during a time of social isolation. In particular, the study elucidated the significance of evaluating health parameters using telehealth, as opposed to leaving patients unsupervised or offering no intervention at all. The results are notable as they suggest that lower limb strength and cardiopulmonary endurance can be improved significantly via a virtual outpatient rehabilitation program. The data are still limited by the timing of the study and the differences in sample sizes among treatment groups. Because the research was conducted early during the first wave of the pandemic and consisted of a disproportionate number of participants in virtual physical therapy and home physical therapy (44 vs 25), its generalizability would benefit from further exploration. Furthermore, there is emerging evidence that patients with SARS-CoV-2 infection are at risk of developing secondary pulmonary fibrosis. 2 A 15-year follow-up from a prospective cohort study of the 2003 SARS outbreak found that~38% had pulmonary fibrosis, evidenced by ground-glass opacities or cord-like consolidations on computed tomography scan of the chest. Zhang et al found that recovery of these lesions occurred to a greater extent in the first year and then remained stable or progressive until 2018, at the end of the 15 -year study. 3 Although data are not yet available on the long-term impact of COVID-19, the aberrant lung remodeling and fibroproliferation associated with infection are concerning for patients developing progressive fibrotic lung disease. As an example, pulmonary rehabilitation enhances exercise capacity and improves the quality of life in patients with idiopathic pulmonary fibrosis. 4 Similarly, for patients with COVID-19 who are able to attend in-person therapy, pulmonary rehabilitation may be of great benefit. For those who are not able to participate with in-person therapy, we feel optimistic that virtual outpatient programs like the program conceived of by Hameed and colleagues will increase access to essential rehabilitation and improve clinical outcomes for COVID-19 survivors. We are interested in further follow-up of this cohort and their clinical outcomes. Knowledge of the unforeseen sequelae of the COVID-19 pandemic has necessitated ongoing adaptation of how we provide care. The development of post-SARS-CoV-2 infection recovery programs is unprecedented and occurring during a time of limited resources. In a similar fashion, Steere et al utilized telemedicine as a component of their ambulatory post-COVID-19 recovery programs in Boston and New York City. 5 Notably, there was a difference in discharge disposition patterns between the cohorts, wherein patients in Boston were more likely to be discharged to an inpatient rehabilitation facility and those in New York City were more likely to be discharged to home. The authors suggest that these findings may be due to differences in utilization of inpatient rehabilitation beds as acute care hospital beds when additional inpatient services were needed due to the surge in COVID-19 cases. Given the timing of the data collection, it would be interesting to see how the discharge disposition patterns have changed as COVID-19 case numbers have changed. These variations may demonstrate the need for readjustment in how we treat patients after acute recovery from COVID-19 and thereby the ongoing adaptability of health care delivery. Furthermore, in both New York City cohorts, the majority of participating patients were identified as Hispanic. This may relate to the community health care disparities in rates of COVID-19 experienced by the Hispanic community, with a higher percentage of individuals who live in New York City compared to Boston. We appreciate the advancement of the literature base with this study demonstrating the comparable utility of virtual physical therapy. We hope that such programs continue to be explored as a way of creative and even culturally conscious health care delivery. We hope that such programs continue to be supported by institutions as well as insurance providers as part of mitigating the Outcomes of a COVID -19 recovery program for patients hospitalized with SARS-CoV -2 infection in New York City: a prospective cohort study Healing after COVID-19: are survivors at risk for pulmonary fibrosis? Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study Pulmonary rehabilitation for exercise tolerance and quality of life in IPF patients: a systematic review and meta-analysis Ambulatory rehabilitation of patients hospitalized with SARS CoV -2 infections: early pandemic experience in New York City and Boston Disclosure: The authors have no disclosures related to this work. Ihuoma O. Njoku https://orcid.org/0000-0002-0214-7378